Biodegradable Bone Graft Polymers Market Introduction
Biodegradable bone graft polymers are synthetic or natural materials used to replace or repair damaged bone tissues. These polymers can be used alone or in combination with bone graft substitutes and biomaterials to enhance their mechanical and biological properties. The biodegradable bone graft polymers are designed to gradually degrade and be replaced by newly formed bone tissue, thereby promoting bone healing and regeneration.The market for biodegradable bone graft polymers is expected to grow significantly in the coming years due to the increasing prevalence of bone disorders, such as osteoporosis and osteoarthritis, and the rising number of orthopedic surgeries worldwide. Moreover, the growing demand for minimally invasive surgical procedures and the increasing awareness about the benefits of biodegradable bone graft polymers over traditional bone grafts are driving the growth of the market. Additionally, the availability of government funding for research and development activities is expected to fuel the market growth.
Biodegradable Bone Graft Polymers Market Size
The global biodegradable bone graft polymers market size was valued at USD 404.3 million in 2020 and is expected to reach USD 704.2 million by 2028, growing at a CAGR of 7.1% from 2021 to 2028.The growth of the market is attributed to the increasing prevalence of bone disorders and the rising number of orthopedic surgeries worldwide. In addition, the growing demand for minimally invasive surgical procedures and the increasing awareness about the benefits of biodegradable bone graft polymers over traditional bone grafts are driving the growth of the market. Moreover, the availability of government funding for research and development activities is expected to fuel the market growth.On the basis of type, the synthetic biodegradable bone graft polymers segment is expected to account for the largest share of the market in 2028. By application, the orthopedic surgery segment is expected to hold the largest share of the market in 2028. By region, North America is expected to dominate the market during the forecast period, followed by Europe and Asia Pacific.
Biodegradable Bone Graft Polymers Market Share
The global biodegradable bone graft polymers market is fragmented and highly competitive, with several players operating in the market. The market share is distributed among various key players, including:
Evonik Industries AG
Corbion N.V.
KLS Martin Group
Stryker Corporation
Heraeus Holding GmbH
PolyNovo Limited
Poly-Med, Inc.
Zimmer Biomet Holdings, Inc.
Berkeley Advanced Biomaterials, Inc.
CollPlant Ltd.
In terms of market share, Evonik Industries AG held the largest share of the market in 2020, followed by Corbion N.V. and KLS Martin Group. These companies are continuously investing in research and development activities to develop new and innovative products to cater to the growing demand for biodegradable bone graft polymers. Moreover, strategic partnerships, collaborations, and mergers and acquisitions are some of the key strategies adopted by these players to maintain their market position and expand their customer base.
Biodegradable Bone Graft Polymers Market Trends
Some of the key trends observed in the biodegradable bone graft polymers market include:
Increasing demand for minimally invasive surgical procedures: There has been a growing trend towards minimally invasive surgical procedures, which require specialized materials that can be easily applied and molded to fit the bone defect site. Biodegradable bone graft polymers provide an ideal solution for such procedures due to their ability to be molded and resorb over time.
Growing focus on product development: Companies operating in the market are investing heavily in research and development activities to develop new and innovative products to cater to the growing demand for biodegradable bone graft polymers. They are also focusing on improving the performance of existing products by enhancing their mechanical properties, bioactivity, and biodegradability.
Increasing adoption of synthetic bone graft substitutes: Synthetic bone graft substitutes are gaining popularity due to their excellent biocompatibility, biodegradability, and osteoconductivity. Biodegradable bone graft polymers are widely used as a component of synthetic bone graft substitutes due to their ability to mimic the natural bone matrix and promote bone growth.
Rising prevalence of bone disorders: The prevalence of bone disorders such as osteoporosis, osteoarthritis, and bone cancer is increasing globally. This is driving the demand for biodegradable bone graft polymers, which are used to treat bone defects caused by these disorders.
Growing focus on sustainable healthcare: There is a growing focus on sustainable healthcare, which includes the use of environmentally friendly products. Biodegradable bone graft polymers are eco-friendly and sustainable, making them an ideal choice for healthcare providers who are looking to reduce their environmental footprint.
Biodegradable Bone Graft Polymers Market Driving factors
The biodegradable bone graft polymers market is driven by several factors, including:
Increasing prevalence of bone disorders: The prevalence of bone disorders such as osteoporosis, osteoarthritis, and bone fractures is increasing globally. This is driving the demand for bone grafts, which in turn is fueling the growth of the biodegradable bone graft polymers market.
Rising geriatric population: The aging population is at a higher risk of developing bone disorders, as bones become weaker and more prone to fractures with age. The increasing geriatric population is therefore expected to boost the demand for biodegradable bone graft polymers.
Advancements in medical technology: Advancements in medical technology have led to the development of new and innovative bone grafting materials, including biodegradable bone graft polymers. This has led to increased adoption of these products, thereby driving market growth.
Favorable government initiatives: Governments in several countries are promoting the use of biodegradable bone graft polymers by offering subsidies and tax incentives for their production and use. This is expected to drive market growth in the coming years.
Growing awareness about the benefits of biodegradable bone graft polymers: Patients are becoming increasingly aware of the benefits of biodegradable bone graft polymers, such as reduced risk of infection and better biocompatibility with the body. This is expected to drive demand for these products in the future.
Biodegradable Bone Graft Polymers Market Regional Analysis
The biodegradable bone graft polymers market can be analyzed on a regional basis, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.North America is expected to have a significant share in the biodegradable bone graft polymers market due to the high prevalence of bone-related disorders, growing geriatric population, and increased healthcare expenditure in the region.Europe is also projected to have a significant share in the market due to the growing prevalence of osteoporosis and osteoarthritis and the increasing demand for bone graft substitutes.The Asia-Pacific region is expected to have a substantial growth rate in the market due to the increasing healthcare expenditure, growing awareness about bone-related disorders, and the presence of a large patient pool.Latin America and the Middle East and Africa are also expected to show significant growth in the market due to the rising prevalence of bone-related disorders and increasing healthcare expenditure in these regions.
Overall, the biodegradable bone graft polymers market is expected to have significant growth potential across all regions due to the increasing demand for minimally invasive surgeries and the growing prevalence of bone-related disorders.
Biodegradable Bone Graft Polymers Market Forecasts 2030
Biodegradable Bone Graft Polymers Market Key Industry Players
Some of the key industry players operating in the biodegradable bone graft polymers market include:
Evonik Industries AG
KLS Martin Group
Corbion N.V.
Poly-Med, Inc.
Wright Medical Group N.V.
Stryker Corporation
CollPlant Holdings Ltd.
Geistlich Pharma AG
Zimmer Biomet Holdings, Inc.
Invibio Ltd.
This is not an exhaustive list, as there are many other players operating in the market as well.